Calliditas Therapeutics
@calliditas.se
Calliditas is a commercial stage biopharmaceutical company focused on identifying, developing and commercializing novel treatments in orphan indications, with an initial focus on renal and hepatic diseases with significant unmet medical needs.
Calliditas Therapeutics's Company Logos
Calliditas Therapeutics's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#1A79C0
Denim
26, 121, 192
206, 76, 43
86, 37, 0, 25
#FECDA5
Flesh
254, 205, 165
27, 98, 82
0, 19, 35, 0
#101214
Woodsmoke
16, 18, 20
210, 11, 7
20, 10, 0, 92
About Calliditas Therapeutics
Calliditas Therapeutics is a commercial stage biopharmaceutical company dedicated to identifying, developing, and commercializing innovative treatments for orphan indications, specifically focusing on renal and hepatic diseases with significant unmet medical needs. Leveraging their expertise in pharmaceutical product development and strategic partnerships, Calliditas quickly and efficiently brings new treatment options to patients with rare diseases. They have successfully commercialized their lead candidate in the United States and launched it in Europe in collaboration with their partners, with plans for approval in Asia.
Led by an experienced and dedicated management team, Calliditas prioritizes expanding treatment options and establishing new standards of care for those patients who need it most. With a strong focus on research and development, they aim to improve the lives of patients by continuously innovating and introducing new medicines. Calliditas Therapeutics is committed to making a positive impact in the field of biopharmaceuticals and addressing unmet medical needs for patients with rare diseases
Brand industry
Health
Company type
Suggest company type
Year founded
Suggest founded year
Company size
51-200 employees
Related Brands
Tags
Orphan drug development
Rare disease therapeutics
Renal disease treatments
Hepatic disease treatments
Biopharmaceutical commercialization
